Regenerative Medical Technology Group Inc. (RMTG)
OTCMKTS · Delayed Price · Currency is USD
0.0400
+0.0010 (2.56%)
Feb 12, 2026, 2:47 PM EST

RMTG Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-7.06-5.56-9.81-5.51-12.88-5.9
Depreciation & Amortization
0.150.220.310.150.040
Other Amortization
0.582.133.061.760.891.85
Asset Writedown & Restructuring Costs
--4.13---
Stock-Based Compensation
--00.010.280.17
Other Operating Activities
0.420-1.52-0.080.262.46
Change in Accounts Receivable
-0.0800.03-0.03-0-
Change in Inventory
-0.15-0.01----
Change in Accounts Payable
5.84.13.412.521.311.09
Change in Other Net Operating Assets
-0.03-0.03-0.02-0.24-
Operating Cash Flow
-0.370.85-0.42-1.11-9.88-0.32
Capital Expenditures
-0.39-0.22-0.39-0.2--
Cash Acquisitions
----0.67-0.18
Investing Cash Flow
-0.39-0.22-0.39-0.20.67-0.18
Long-Term Debt Issued
----12.40.7
Total Debt Issued
1.1---12.40.7
Long-Term Debt Repaid
---0.01-0.02-0.25-0.03
Total Debt Repaid
---0.01-0.02-0.25-0.03
Net Debt Issued (Repaid)
1.1--0.01-0.0212.150.68
Other Financing Activities
---0.3---
Financing Cash Flow
1.1--0.31-0.0212.150.52
Net Cash Flow
0.350.64-1.11-1.332.940.02
Free Cash Flow
-0.750.64-0.8-1.31-9.88-0.32
Free Cash Flow Margin
-14.90%15.47%-33.40%-85.78%-2255.99%-585.94%
Free Cash Flow Per Share
-0.060.05-0.07-0.11-0.86-0.04
Cash Interest Paid
--000-
Levered Free Cash Flow
1.82.760.590.57-4.74-5.81
Unlevered Free Cash Flow
5.254.161.591.56-3.93-5.03
Change in Working Capital
5.544.063.422.491.551.09
Source: S&P Global Market Intelligence. Standard template. Financial Sources.